Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y5ED
|
||||
Former ID |
DIB015617
|
||||
Drug Name |
AV-203
|
||||
Synonyms |
ErbB3-targeted antibodies (cancer), AVEO/Biogen Idec
|
||||
Drug Type |
Antibody
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [523911] | ||
Company |
Aveo oncology
|
||||
Target and Pathway | |||||
Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | [533093] | ||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
EGF receptor signaling pathway | |||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
ErbB receptor signaling network | |||||
a6b1 and a6b4 Integrin signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.